window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 19, 2025

  • News
  • About Us
Contact Us

AI

  • Artificial Intelligence,Technology and platforms,Women in Pharma

    AI governance in pharmacovigilance: Marie Flanagan calls for safety-specific frameworks to safeguard patient risk

    The integration of artificial intelligence into pharmacovigilance is prompting a [...]

    June 2, 2025
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Imlifidase enables gene therapy for Crigler–Najjar patients with AAV immunity
    Categories: Biomanufacturing, Cell & Gene Therapy, Clinical Development, Rare Diseases, Regulatory Affairs
  • Grifols’ Biotest launches Yimmugo in United States after FDA approval
    Categories: Biomanufacturing, Pharmaceuticals and therapeutics, Rare Diseases, Regulatory Affairs
  • Agentic AI in pharma and how it could transform clinical trials
    Categories: Artificial Intelligence, Clinical Trials, Data Management, Drug Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top